PKvitality enters into a key partnership with Beurer Gmbh
Beurer Gmbh, one of the top 3 distributors of Blood Glucose meters in Germany, Austria and Italy, invests 2.25m€ in PKvitality to help further develop the K’Watch and begin human clinical trials.
By Prakhar, January 7, 2019
PKvitality wins EIThealth European Health Catapult!
PKvitality has won EIT Health Catapult contest held in Paris, France on 2nd December, in the medtech category.
By Prakhar, December 3, 2019
Dassault Systèmes is world’s leading vendor of 3D Modelling, Simulation and Project Lifecycle Management software.
By Prakhar, November 27, 2019
The advisory board consists of John Brooks, the creator of tubeless insulin pump and Alexandre Richard, the director of corporate M&A at Sanofi.
By Prakhar, November 26, 2019
PKvitality is the only French start-up to reach the med-tech finals, which will take place in Paris in early December 2019.
By Prakhar, October 18, 2019
We will be present:
– On May 16th and 17th on the INPI booth in the Accelerate area in Hall 1 n°H47.
– On May 18th on the Orange booth in Hall 1 n°J09-158.
By Alice, May 13, 2019
The PKvitality team will be present at the MedTech and Biotech Showcases at San Francisco. Satellite event of the JP Morgan Healthcare Conference, the Biotech Showcase is a must-attend business convention in the field of biotechnology.
By Alice, January 07, 2019
K’Watch will be able to measure the glucose (and Lactate for the Athlete version in continuous mode). K’Watch can now be considered as a CGM (Continuous Glucose Monitoring) device.
This decision has been possible thanks to all the remarks you made, by email or while visiting our stands at CES, Vivatech or other tradeshows.
By Kévin, December 06, 2018
We are proud to have been invited again to participate in the Viva Technology Paris event, the largest technological startup show in european, in May 25, 26th 2018, at Porte de Versailles – Paris. Thanks to all of those who came to visit our booth, we were happy to share our updates with you, and with whom were curious about technologies that will change people’s life.
By Aimée, July 18, 2018
We are excited to announce that PKvitality received Seal of Excellence from the European Commission H2020 instrument Phase 2. Following evaluation by an international panel of independent experts, K’Watch glucose is scored as a high-quality project proposal in a highly competitive evaluation process.
By Aimée, June 28, 2018
We are part of the 8 French Medtech companies selected to participate to the Soft Landing Boston 2018 program. Soft Landing Boston is a program dedicated to medtech and e-health companies (medical devices, connected objects and tools for diagnosis and monitoring).
By Hugo, March 5, 2018
The K’Watch project is rewarded once again in the most beautiful way. We are indeed proud to be the winner of the Digital Innovation Contest (Concours Innovation Numérique or CIN in french) organized by the Public Investment Bank (BPIfrance).
BPIfrance funds us with more than 1M€, a mix of subsidy and loan. This will enable us to fund the development of the project in the coming months.
By Hugo, December 4, 2017
Our crowdfunding campaign has finally ended after being extended for one and a half months due to an outpour of requests. We were more than glad to have extended the campaign to cater to more of you, and we are truly grateful to all those who participated.
By Hugo, September 12, 2017
PKvitality is one of only two French MedTech companies selected for the european EIT Health Catapult competition. This contest is organized by the European Institute of Innovation and Technology , an independent EU body which dedicate to enhance Europe’s innovative competitiveness by supporting new ideas and nurturing entrepreneurial talent .
By Aimée, July 19, 2017
We are pleased to announce that we are now an official laureate of the SME Instrument Phase 1 (Horizon 2020), which is the innovation and research program of the European Union. Endowed with 50,000 €, this program is one of the most selective and honors only less than 10% of the promising projects.
By Aimée, July 05, 2017
PKvitality is proud to have been selected by SANOFI to be present in their Lab during the Viva Technology fair from the 15th to the 17th of June 2017, in Paris, France. Head over to Sanofi booths C11-023 to meet our team and to learn more about K’Watch. We look forward to meeting you!
By Hugo, June 14, 2017
Luck must have been on our side since the the beginning of the year, because as soon as the CES was over, we immediately extended the discussions on K’Watch through the Advanced Technologies & Treatments for Diabetes (ATTD) trade show. This took place from the 15th to the 18th of February in Paris, a stone’s throw away from our premises.
By Hugo, February 25, 2017
After garnering 3 Innovation Awards, K’Watch has been covered by international media .
In addition to coverage from the press, the K’Watch booth was also visited by more than a thousand people. In short, many rewarding contacts have validated that K’Watch adresses a real problem.
By Hugo, January 10, 2017
We had the honor of receiving 3 CES Innovation Awards.
The first in the category Fitness, Sports and Biotech; the second in the Wearable Technologies category. The third is the ultimate recognition — a BEST OF INNOVATION Award in the Tech for a Better World category.
By Hugo, January 3, 2017
PKvitality will be at CES 2017 in Las Vegas to present K’Watch, the connected watch for diabetics.
We have chosen to present our PKvitality brand as well as K’Watch in the CES 2017 in Las Vegas. K’Watch is the first connected watch for diabetics.
By Hugo, January 1, 2017